ClinicalTrials.Veeva

Menu

Using Large Language Models Such As GPT-4 to Assess Guideline Adherence in Patients with Chronic Obstructive Pulmonary Disease (IMPL-AI-MENT)

Charité University Medicine Berlin logo

Charité University Medicine Berlin

Status

Enrolling

Conditions

COPD

Treatments

Other: LLM

Study type

Interventional

Funder types

Other

Identifiers

NCT06410547
EA2/322/23

Details and patient eligibility

About

According to studies in the US and the Netherlands, 33-40% of patients with chronic conditions receive care that does not follow guideline recommendations. These findings have also been demonstrated in the management of COPD. This leads to under- or over-treatment of patients and, in the case of COPD, to exacerbations and hospitalisations. These exacerbations are a significant clinical problem, affecting patient's lung function, quality of life and mortality. They are also a burden on the healthcare system. Technological advances in artificial intelligence offer the opportunity to address these issues in COPD management. In the past year, there have been remarkable innovations in the field of natural language processing, especially through large language models such as GPT-4 from OpenAI and Bard or Gemini from Google. These models offer an opportunity to improve the implementation of evidence-based care in clinical practice.

This study is a prospective, randomised trial that will compare therapy on discharge for patients with COPD. One arm will receive no intervention, while the other arm will receive a treatment recommendation from an LLM. The study will compare the percentage of patients treated according to the guideline.

Enrollment

70 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Diagnosis of COPD
  • Consent
  • Discharge after hospitalization

Exclusion criteria

  • Lack of Consent

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

70 participants in 2 patient groups

No Intervention
No Intervention group
Description:
This arm will be treated as usual. No intervention will be performed.
LLM Assessement
Active Comparator group
Description:
During hospital stay and after written informed consent, an LLM is asked to indicate if the treatment the patient receives is guideline-concordant. The information is ascertained by two study physicians (human-in-the-loop) and later provided to the treating physician who can recommend a change in therapy to the patient (outside of the study).
Treatment:
Other: LLM

Trial contacts and locations

1

Loading...

Central trial contact

Matthias Gröschel, MD PhD; Sylvia Hartmann, MD MPH

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems